Seres Therapeutics (MCRB) awards 50,000 stock options to director-officer
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Seres Therapeutics, Inc. reported that director and officer Richard N. Kender received a grant of stock options covering 50,000 shares of common stock at an exercise price of $9.13 per share. These options vest in 36 equal monthly installments beginning on March 2, 2026, and are scheduled to expire on March 3, 2036. Following this grant, Kender holds stock options for 50,000 shares directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Kender Richard N
Role
See Remarks
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 50,000 | $0.00 | -- |
Holdings After Transaction:
Stock Option (right to buy) — 50,000 shares (Direct, null)
Footnotes (1)
- [object Object]
Key Figures
Options Granted: 50,000 shares
Exercise Price: $9.13 per share
Expiration Date: March 3, 2036
+2 more
5 metrics
Options Granted
50,000 shares
Stock option grant to Richard N. Kender reported as of transaction date July 8, 2026
Exercise Price
$9.13 per share
Conversion or exercise price for the 50,000 stock options
Expiration Date
March 3, 2036
Scheduled expiration date of the granted stock options
Vesting Period
36 months
Options vest in 36 equal monthly installments after March 2, 2026
Post-transaction Option Holdings
50,000 shares
Total stock option shares held directly by Richard N. Kender after the grant
Key Terms
Stock Option, exercise price, vesting commencement date
3 terms
Stock Option financial
"The option vests and becomes exercisable in 36 equal monthly installments"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
exercise price financial
"conversion_or_exercise_price: "9.1300""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting commencement date financial
"following the March 2, 2026 vesting commencement date"
The vesting commencement date is the starting point when an employee begins earning ownership rights to their promised benefits, such as stock options or retirement contributions. Think of it like the day a savings account is opened—only after this date do the benefits start to grow and become fully available over time. It matters to investors because it marks when the clock begins ticking toward full ownership, affecting the timing and value of these benefits.
FAQ
What did insider Richard N. Kender receive in the latest Form 4 for MCRB?
Richard N. Kender received a stock option grant for 50,000 shares of Seres Therapeutics common stock, with an exercise price of $9.13 per share and expiration on March 3, 2036.
How do the 50,000 Seres Therapeutics (MCRB) options granted to Richard N. Kender vest?
The 50,000 stock options granted to Richard N. Kender vest in 36 equal monthly installments starting from the March 2, 2026 vesting commencement date, gradually becoming exercisable over three years.
What is the exercise price of the options reported in the Seres Therapeutics (MCRB) Form 4?
The options reported for Richard N. Kender have an exercise price of $9.13 per share. They relate to Seres Therapeutics common stock and represent a right to buy 50,000 shares at that price.
When do Richard N. Kender’s Seres Therapeutics (MCRB) options expire?
The reported stock options held by Richard N. Kender are scheduled to expire on March 3, 2036. Any unexercised portion after this date will no longer be exercisable under the grant terms.